Autoimmunity in Neuromuscular diseases

Tuesday, May 21, 2024

8:00 AM – 10:30 AM EST

Location:MM: Quebec

CE: 2.5

Audience:

Adult Neurologist, Child Neurologist, Neurophysiologist, Resident, Fellow, Nurses with interest in topic

Learning Level:

Intermediate (Practicing Physician), Advanced (Special Interest, Higher Level Discussion)

Learning Format:

Lecture/plenary method

CanMEDs Roles:

Medical Expert, Scholar

Chair(s)

FM

Fraser Moore

Speaker(s)

SB

Steven Baker
EO

Erin O'Ferrall
CH

Chris Hahn
HK

Hans Katzberg

Our knowledge of immune-mediated disorders of the peripheral nervous system continues to expand. This course is intended to provide an update on current issues and controversies in this field.

Learning Objectives:

Identify one new treatment option for an autoimmune neuromuscular disease that the attendee can apply now in their practice
Describe the clinical features of an autoimmune neuromuscular condition of which the attendee was previously unfamiliar with
Name one novel antibody test that would help them in clinical practice

Presentations:

8:00 AM – 8:05 AM EST

Introduction
Speaker: Fraser Moore
8:05 AM – 8:30 AM EST

Update on CIDP variants and treatment options
Speaker: Steven K. Baker
8:35 AM – 8:40 AM EST

Questions
Speaker: Fraser Moore
8:40 AM – 9:05 AM EST

Update on treatment options of immune mediated myositis and clinical trials
Speaker: Erin O'Ferrall
9:05 AM – 9:10 AM EST

Questions
Speaker: Fraser Moore
9:10 AM – 9:35 AM EST

Paraneoplastic neuromuscular syndromes
Speaker: Chris Hahn
9:35 AM – 9:40 AM EST

Questions
Speaker: Fraser Moore
9:40 AM – 10:05 AM EST

Neuromuscular Hyperexcitability Syndromes
Speaker: Hans Katzberg
10:05 AM – 10:10 AM EST

Questions
Speaker: Fraser Moore
10:10 AM – 10:30 AM EST

Discussion, Wrap up & Specific Course Evaluation
Speaker: Fraser Moore